Wildcat top stock for contrarian lithium bet
Barry FitzGerald says if the consensus has gold and uranium stocks leading the way in 2025, lithium could surprise.
News
Bell Potter’s top tech and health stocks for 2025
Australian stockbroking and financial advisory firm Bell Potter is bullish on these tech stocks and healthcare stocks for 2025.
No Christmas break for Legacy in its tier one quest
Junior explorer Legacy Minerals believes its large landholding and tier one partners position it as having a strong chance of making a major discovery.
How to tap the $33 billion pet care market
The listed Mad Paws and Apiam Animal Health offer rare listed exposures to the lucrative and growing pet care sector.
Private credit poised for growth in 2025
Private credit is set to continue its strong growth trajectory in 2025 according to experts in the sector.
Canary Capital thinks these gold stocks could fly
Canary Capital’s Paul Hart remains bullish on gold and outlines why he’s chosen these three ASX stocks as potentially winning picks for investors.
Leeuwin surges on Marda gold deal
Leeuwin climbs after acquiring the Marda project from Ramelius, while Iltani pops up with high-grade drill results at Orient.
Gold bulls watching more than US rates
MineLife’s Gavin Wendt says gold is his key commodity pick for 2025, with analysts not just basing their bets on interest rates.
ASX hits three-month low
The local bourse hit a three-month low on Friday as CBA led the banks down, Mesoblast gave back some of its 50pc gain and the ASX had a CHESS outage.
Clean energy’s on track – can we speed it up?
Clean energy is moving ahead, believe experts, but with key tech still in diapers, hitting ultimate climate goals is no sure thing.
This biotech fell off its perch this week
Percheron fell ~90% in a week Morgans analyst Scott Power described as one of both good and bad news for the ASX healthcare sector.
Iron ore decline in Canberra crystal ball
Federal government forecasters are continuing to go bearish on iron ore prices, as Australia plans for lower bulk commodity prices.
ASX drops more as Bitcoin falls below US$97k
The ASX has taken another hit on Friday as the Fed’s cautious outlook lingers. Bitcoin has slid below US$97k and gold miners are in retreat.
Radiopharm’s first in-human study
Sarah Hughan details Radiopharm Theranostics’ first in-human study approval for the treatment of breast and gastric cancers.
Caution ahead as Fed turns hawkish
The Fed’s latest interest rate cut of 25 basis points MAY well be its last for the foreseeable future. So… now how to position as investors?
ASX silver stocks to fill your stocking
The ASX silver sector is blossoming after prices shot up almost 30% this year. Stockhead finds the pick of the bunch for your Xmas stocking.
Smart money flows to resources
Resources stocks in may have been sold off this year, but corporate activity shows majors and strategics are planning for the next boom.
ASX graphite stock calls cops on China
Novonix champions investigation into whether China is dumping graphite to force out US competitors.
Patriot recharges on VW lithium deal
Patriot, Cosmos lead gains with big developments in Canadian and Bolivian lithium, while Anax and Trek were among the no-news gainers.
ASX sinks on rate fears, Mesoblast up 52pc
The ASX hit a six-week low on a red Thursday, after the US Federal Reserve struck a more hawkish interest rates-related tone than expected.
MoneyTalks: 15 miners who can navigate choppy seas
Argonaut’s David Franklyn joins Stockhead to traverse the metals and miners he rates to overcome market turbulence.
How gas policy is letting Australia down
Australia needs more gas to offset declining supplies from ageing fields but government policy appears to getting in the way of achieving this goal.
GOT GAS: Kipper easing gas woes? Think again
The start-up of the Kipper Compression Project will keep gas flowing from the Kipper field but its impact on East Coast supplies has already been accounted for.
BlinkLab’s autism product gets global check
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the positive outcome from the US Food and Drug Administration from BlinkLab.
Fed triggers Wall Street (and ASX) sell-off
The ASX plunged nearly 2pc earlier, as a brutal Wall Street sell-off followed the Fed’s cautious outlook, signalling just two rate cuts for 2025.
Guy on Rocks: MNB
Guy Le Page looks into Minbos Resources and a phosphate opportunity to build a breadbasket in a nation which imports all of its fertiliser.
Stem-cell treatment gets breakthrough FDA approval
After years of trying, Mesoblast has won US FDA approval for its stem-cell therapies to treat the fatal graft-versus-host disease.
Volkswagen buys stake in PMT
Stockhead TV’s Sarah Hughan delves into a Volkswagen deal with Patriot Battery Metals and its North American lithium.
Brinsden’s Patriot inks major lithium deal
Volkswagen battery subsidiary PowerCo will pay C$69 million for a 9.9% stake in Canadian lithium hopeful Patriot Battery Metals.
Webull: 4 factors to boost ASX in 2025
Webull’s Talevski predicts rate cuts and US market momentum will boost the ASX in 2025, with the mining sector leading growth.
Why Copper M&A is just starting
Every major has copper at the top of its wishlist. And if you thought 2024’s M&A rush was big, just wait for what 2025 has in store.
Mali gold miners see support
Is the worst over for Mali gold miners? Bets today on ASX gold names suggest some investors may think so.
ASX slips as Fed looms
The ASX closed just into the red on Wednesday, ahead of another important Fed decision.
Rhythm hits 2024 key milestones
Predictive cancer diagnostics company Rhythm Biosciences reports it has attained all key milestones for 2024.
ASX up as MinRes seals $780m deal
ASX steadies ahead of the Fed decision. Mining leads but Percheron’s value plummets after poor trial results.
Break it Down: Pennys Find PFS
Sarah Hughan tells all on Horizon Minerals’ PFS and ore reserve for its Pennys Find project in WA’s Eastern Goldfields.
Percheron shares tumble on clinical trial failure
Percheron Therapuetic’s key trial for Duchenne muscular dystrophy has flopped, sending the shares into freefall.
The ASX resources sector looks strong in 2025
Investment manager Emanuel Datt believes Australia’s resources sector is emerging as a strong opportunity in 2025 and narrows in on three stocks.
Painchek eyes lucrative US market
Having tackled the local and UK aged-care markets, Painchek has its eyes on the much bigger US nursing home sector.
Speeding ticket can’t slow Cyclone
Cyclone Metals rose for a second straight trading day on no news, while BPM wrapped up drilling near the Mt Gibson gold mine.
ASX leaps; Novonix, Bitcoin soar
The ASX rose on Tuesday, with banks leading, while energy lagged. As for Bitcoin… its moon mission continues.
Datt forecasts US$3000/oz gold
Datt Capital founder and chief investment officer Emanuel Datt forecasts gold prices will continue to rise and may soon hit $US3000/oz.
ASX up; Bitcoin hits record on US reserve plans
The ASX opened higher on Tuesday but energy stocks weighed on the index. Meanwhile Bitcoin hit another record high amid US reserve plans.
Clinical trials results flow fast in pre-yuletide rush
The year is ending with an ongoing strong flow of clinical results – and is unlikely to abate in 2026.
Novonix’ potential US$755m loan
Stockhead TV’s Sarah Hughan brings you today’s Break it Down, detailing the proposed synthetic graphite plant in the US from Novonix.
Intra Energy outlines strong gold anomaly at Maggie Hays Hill ahead of drilling
Intra Energy outlines strong gold anomaly at Maggie Hays Hill ahead of drilling
ASX rallies 1.75pc on easing inflation read
ASX surges 1.75pc after CPI “good enough to rule out an interest rate hike”.
Stockhead: ASX Small Caps Weekly Wrap
Despite a horror Friday, the market managed a win this week.
Top 10 at 11: Fresh from the ASX today
Stockhead’s Top 10 at 11: a short, sharp update to help frame the trading day.
ASX up; CBA, Mac Bank hit records; Aruma doubles
UBS analysts recommend buying ASX bank stocks due to better short-term prospects despite high valuations.
All you need to know before the ASX opens
Here’s everything you need to know, and some things you don’t, before the ASX opens today.
Benchmark and goldies in good form
Local benchmark ticks up after solid showing on Wall Street late Friday.
MinRes falters as Ordell soars on gold find
ASX closes higher despite a big dip in Mineral Resources, while the US dollar weakens amid uncertain election polling.
Why gold could outperform under Trump
Trump’s imminent return to the White House has brought a dive in gold prices. But experts think that could be short-lived.
Crucible: Dr Boreham’s A-To-Z of 2024 biotech
From AI to zygotes, the biotech sector this year delivered the A to Z of excitement, intrigue, occasional disappointment and downright disaster.
Can Adore Beauty’s new CEO turn it around?
Adore Beauty faces growth challenges but new CEO Sacha Laing is aiminf for a 30pc revenue boost and tripling of margins in three years.
Control Bionics eyes ‘near term’ profitability
Assistive communications group Control Bionics says it has overcome recent challenges including slow NDIS billing.
Iltani up on high-grade silver
Iltani surges on silver hit, Emmerson in gold takeover frame says Bridge Street and Patriot revives Zambian copper deal.
Santa rally stalls as China data hits
The ASX dropped on Monday as miners and tech slid and China’s weak data impacted commodities. Meanwhile, Bitcoin hit ANOTHER record high.
Iron ore drags miners; Digico drops again
Iron ore drags ASX miners, Digico and Ventia slump, Chalmers announces RBA shake-up.
Anteris debuts on the Nasdaq exchange
The heart valve innovator has started trading on the Nasdaq, as part of a US$88 million initial public offer.
Silver deposit already “looks like a mine”
Market observers are buzzing about the potential of Maronan Metals’ Queensland silver deposit of the same name.
Commsec’s ASX “Strong Buys”
Top “strong buy” stocks include Life360, West African Resources, and leaders in mining, biotech, and energy.
Crisis? What crisis? Troubled shares will (usually) recover
Investors can profit from investing in the midst of a corporate disaster – but they need nerves of steel.
ASX set for weekly loss as miners, real estate slump
The ASX drops as Wall Street weakness weighs on sentiment, with Insignia outperforming and Rio Tinto slumping.
Auric Mining banks another $5M
arah Hughan tells all on Auric Mining’s $5.2m returns from the latest round of gold sales at its Jeffreys Find mine near Norseman in WA’s Goldfields.
Why 2025 could be the year for ASX small caps
ASX small caps could rebound in 2025, Shaw and Partners analysts say, with lower interest rates boosting growth along with diversification and returns.
James Bay on fast track in Nevada
While miners say red tape is making Australia increasingly uncompetitive, the same can’t be said of Nevada, where junior goldie James Bay is thriving.
ASX slides; DigiCo REIT drops on IPO debut
The ASX hits near 4-week low, led by losses in miners, as DigiCo Infrastructure REIT underwhelms in IPO debut today
What is Project 2025 and its ESG impact?
Project 2025 pushes US reforms, raises climate risks, and could impact Australia’s trade and security.
Analysing Sonic’s $700m German health deal
Morgans analyst Scott Power places his watchful eye on the ASX healthcare sector’s big story this week: Sonic Healthcare’s ~$700 million deal to buy a major German laboratory group.
Raiden drills spinning, results expected soon
While drilling is underway at Target area 7, Raiden also expects to imminently receive results from earlier drilling at Andover South.
Gold catalysts laid bare for 2025
The World Gold Council sees “rangebound” gold prices in 2025 with potential upside after strongest growth in over a decade.
Rio goes all in on lithium
Rio Tinto has reinforced its conviction lithium prices will rebound, pledging US$2.5bn ($3.9bn) to build the 60,000tpa Rincon project in Argentina.
IML fundie believes Hipages is undervalued
As the tradies market embraces digitalisation, Hipages is positioning itself to capitalise and capture the $141 billion local industry.
2025 IPO hopeful tackling global “infant killer”
Slated to list on the ASX next year, Nexsen Biotech has developed a simple device to diagnose the infant killer group B streptococcus.
Net zero goals still need hydrogen
Heavy transport and displacing fossil fuel-derived hydrogen are some of the key areas where clean hydrogen can shine.
Argentine lithium junior drawing major eyes
Pursuit Minerals says its increased resource in Argentina opens the door to significant offtake discussions despite sluggish lithium prices.
Pilbara up on insider buys, Bitcoin surges again
The ASX ended lower on Thursday after a stronger-than-expected jobs report, while Downer EDI and Venti plunged after price-fixing allegations by ACCC.
Aldoro teases niobium discovery
More niobium rich surface samples have punters hoping for something big from Aldoro’s diamond drilling at the Kameelburg project.
Original URL: https://www.news.com.au/finance/business/stockhead/news/page/10